Willems Hubertine M E, Ahmed Salman S, Liu Junyan, Xu Zhenbo, Peters Brian M
Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
School of Food Science and Engineering, South China University of Technology, Guangzhou 510641, China.
J Fungi (Basel). 2020 Feb 25;6(1):27. doi: 10.3390/jof6010027.
, along with other closely related species, are the primary causative agents of vulvovaginal candidiasis (VVC)-a multifactorial infectious disease of the lower female reproductive tract resulting in pathologic inflammation. Unlike other forms of candidiasis, VVC is a disease of immunocompetent and otherwise healthy women, most predominant during their child-bearing years. While VVC is non-lethal, its high global incidence and profound negative impact on quality-of-life necessitates further understanding of the host and fungal factors that drive disease pathogenesis. In this review, we cover the current state of our understanding of the epidemiology, host response, fungal pathogenicity mechanisms, impact of the microbiome, and novel approaches to treatment of this most prevalent human candidal infection. We also offer insight into the latest advancements in the VVC field and identify important questions that still remain.
与其他密切相关的物种一起,是外阴阴道念珠菌病(VVC)的主要病原体——一种导致病理性炎症的女性下生殖道多因素感染性疾病。与其他形式的念珠菌病不同,VVC是免疫功能正常且其他方面健康的女性所患的疾病,在育龄期最为常见。虽然VVC不会致命,但其在全球的高发病率以及对生活质量的严重负面影响,使得有必要进一步了解驱动疾病发病机制的宿主和真菌因素。在这篇综述中,我们涵盖了目前我们对这种最常见的人类念珠菌感染的流行病学、宿主反应、真菌致病机制、微生物组的影响以及新的治疗方法的理解现状。我们还深入探讨了VVC领域的最新进展,并确定了仍然存在的重要问题。